Terms: = Breast cancer AND RECQL4, RecQ4, 9401, ENSG00000160957, RECQ4, RTS AND Diagnosis
7 results:
1. A Novel Germline Pathogenic Variant of
Amin M; Mahmoodi-Khaledi E; Narrei S; Zeinalian M
Iran J Med Sci; 2023 Jul; 48(4):420-424. PubMed ID: 37456212
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract] [Full Text] [Related]
3. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract] [Full Text] [Related]
4. Can Radiologic Tumor Size Following Neoadjuvant Therapy Reliably Guide Tissue Resection in breast Conserving Surgery in Patients with Invasive breast cancer?
Walcott-Sapp S; Srour MK; Lee M; Luu M; Amersi F; Giuliano A; Chung A
Am Surg; 2020 Oct; 86(10):1248-1253. PubMed ID: 33284669
[TBL] [Abstract] [Full Text] [Related]
5. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA breast cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract] [Full Text] [Related]
6. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D
Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy for breast cancer--"one fits all"?
Bergh J
Breast; 2005 Dec; 14(6):564-9. PubMed ID: 16243525
[TBL] [Abstract] [Full Text] [Related]
